RA Capital Management, LLC, Director, 10% Owner at Kala Pharmaceuticals, Inc. (KALA), bought 4,848,484 shares at $8.25 ($40.0M) on 2018-10-03, disclosed to the SEC on 2018-10-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.25 | 2,424,242 | $20.0M | 50.0% |
| 2 | $8.25 | 2,424,242 | $20.0M | 50.0% |
| Total | $8.25 avg | 4,848,484 | $40.0M | 100% |
| Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |
| KALV | BUY | 2017-10-16 | $7.2M | — | Filing → |